The Europe swabs collection kit market is expected to grow from US$ 1,144.93 million in 2021 to US$1,542.76 million by 2028. It is estimated to grow at a CAGR of 4.4% from 2021 to 2028.
A swabs collection kit is one of the important tools used among medical devices technologies such as vitals and reagents, to collect samples for laboratory examination. The high demand for sample collection kits, owing to the COVID-19 pandemic, and approval of new & advanced detection tests by authorities are the key factors that are expected to drive the market. Continuous R&D activities, significant investments, and focus on the development of reagents and kits formulations for sample detection and testing are anticipated to fuel the market growth. Moreover, various players and government initiatives have developed integrated platforms to increase the functionality of diagnostic analysis and sensing. For instance, in May 2020, the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Everlywell, Inc. for the COVID-19 Test Home Collection Kit. The product is a standalone, at-home nasal swab sample collection kit that can be sent to specified labs for subsequent COVID-19 diagnostic testing. Nasopharyngeal sampling is considered safe, despite adjacent vital structures.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe swabs collection kit market at a good CAGR during the forecast period.
Based on country, the Europe swabs collection kit market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the market in 2020.
BD; Puritan Medical Products Company LLC; Laboratory Corporation of America Holdings; HiMedia Laboratories; THERMO FISHER SCIENTIFIC INC.; Hardy Diagnostics; VIRCELL SL; BTNX, Inc; Formlabs; Quidel Corporation; DiaSorin S.P.A; Copan Italia SPA; Norgen Biotek Corp; Hologic, Inc; Quest Diagnostics Incorporated; Abbott; Lynn Peavey Company; and QIAGEN by Altair are the leading companies in the Europe swabs collection kit market.
A swabs collection kit is one of the important tools used among medical devices technologies such as vitals and reagents, to collect samples for laboratory examination. The high demand for sample collection kits, owing to the COVID-19 pandemic, and approval of new & advanced detection tests by authorities are the key factors that are expected to drive the market. Continuous R&D activities, significant investments, and focus on the development of reagents and kits formulations for sample detection and testing are anticipated to fuel the market growth. Moreover, various players and government initiatives have developed integrated platforms to increase the functionality of diagnostic analysis and sensing. For instance, in May 2020, the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Everlywell, Inc. for the COVID-19 Test Home Collection Kit. The product is a standalone, at-home nasal swab sample collection kit that can be sent to specified labs for subsequent COVID-19 diagnostic testing. Nasopharyngeal sampling is considered safe, despite adjacent vital structures.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe swabs collection kit market at a good CAGR during the forecast period.
Europe swabs collection kit Market Segmentation
The Europe swabs collection kit market is analyzed on the basis of type, application, and country. Based on type, the market is segmented into nasopharyngeal swabs, oropharyngeal swabs, and others. The nasopharyngeal swabs dominated the market in 2020. Based on application, the market is segmented into microbiology laboratories, diagnostic laboratories, hospitals and clinics, home tests, and others. The hospitals and clinics segment dominated the market in 2020.Based on country, the Europe swabs collection kit market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the market in 2020.
BD; Puritan Medical Products Company LLC; Laboratory Corporation of America Holdings; HiMedia Laboratories; THERMO FISHER SCIENTIFIC INC.; Hardy Diagnostics; VIRCELL SL; BTNX, Inc; Formlabs; Quidel Corporation; DiaSorin S.P.A; Copan Italia SPA; Norgen Biotek Corp; Hologic, Inc; Quest Diagnostics Incorporated; Abbott; Lynn Peavey Company; and QIAGEN by Altair are the leading companies in the Europe swabs collection kit market.
Table of Contents
1. Introduction
3. Research Methodology
4. Europe Swabs Collection Kit Market- Market Landscape
5. Europe Swabs Collection Kit Market - Key Market Dynamics
6. Swabs Collection Kit Market- Europe Analysis
7. Europe Swabs Collection Kits Market Analysis - By Type
8. Europe Swabs Collection Kits Market Analysis - By Application
9. Europe Swabs Collection Kit Market - Country Analysis
10. Industry Landscape
11. Company Profiles
12. Appendix
List of Figures
List of Tables
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BD
- Puritan Medical Products Company LLC
- Laboratory Corporation of America Holdings
- HiMedia Laboratories
- THERMO FISHER SCIENTIFIC INC.
- Hardy Diagnostics
- VIRCELL S.L
- BTNX, Inc
- Formlabs
- Quidel Corporation
- DiaSorin S.P.A
- Copan Italia S.P.A
- Norgen Biotek Corp
- Hologic, Inc
- Quest Diagnostics Incorporated
- Abbott
- Lynn Peavey Company
- QIAGEN
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 157 |
| Published | July 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1144.93 Million |
| Forecasted Market Value ( USD | $ 1542.76 Million |
| Compound Annual Growth Rate | 4.4% |
| Regions Covered | Europe |
